Key Points
- EVP Mark Brosius sold 61 Intuitive Surgical shares at an average price of $441.60, generating $26,937.60. The Rule 10b5-1 transaction reduced his direct holdings by 9.5% to 581 shares.
- Intuitive Surgical reported a strong quarter, with revenue rising 21.7% year over year to $3.05 billion and EPS of $3.00, beating analysts’ estimates of $2.91 billion and $2.65, respectively.
- Wall Street remains broadly positive, with a “Moderate Buy” consensus rating and an average price target of $493.54, although insider selling and concerns about margins and the stock’s premium valuation may weigh on sentiment.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) EVP Mark Brosius sold 61 shares of the company's stock in a transaction dated Wednesday, October 28th. The shares were sold at an average price of $441.60, for a total transaction of $26,937.60. Following the transaction, the executive vice president directly owned 581 shares of the company's stock, valued at approximately $256,569.60. This trade represents a 9.50% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Mark Brosius also recently made the following trade(s):
- On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $451.75, for a total value of $27,556.75.
- On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total transaction of $9,144.75.
- On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total transaction of $8,054.60.
- On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $361.23, for a total transaction of $16,616.58.
- On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89.
- On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $394.26, for a total transaction of $30,358.02.
- On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total transaction of $30,081.59.
- On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The stock was sold at an average price of $351.00, for a total transaction of $9,828.00.
Intuitive Surgical Trading Down 0.4%
Shares of ISRG opened at $444.18 on Thursday. The firm's 50-day moving average price is $399.37 and its 200-day moving average price is $435.44. The firm has a market capitalization of $153.97 billion, a price-to-earnings ratio of 53.71, a PEG ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company had revenue of $3.05 billion for the quarter, compared to analysts' expectations of $2.91 billion. During the same quarter in the previous year, the company earned $2.40 earnings per share. Intuitive Surgical's quarterly revenue was up 21.7% on a year-over-year basis. On average, research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.
More Intuitive Surgical News
Here are the key news stories impacting Intuitive Surgical this week:
- Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
- Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
- Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
- Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
- Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors
Institutional Inflows and Outflows
Institutional investors have recently modified their holdings of the business. Bank of America Corp DE increased its stake in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider's stock valued at $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. Bank of New York Mellon Corp purchased a new position in shares of Intuitive Surgical during the second quarter valued at approximately $1,335,753,000. Amundi lifted its holdings in shares of Intuitive Surgical by 8.6% during the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider's stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the last quarter. Arrowstreet Capital Limited Partnership lifted its holdings in shares of Intuitive Surgical by 95.3% during the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider's stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the last quarter. Finally, Janus Henderson Group PLC boosted its position in shares of Intuitive Surgical by 3.7% in the 1st quarter. Janus Henderson Group PLC now owns 1,643,060 shares of the medical equipment provider's stock worth $757,489,000 after purchasing an additional 58,587 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
ISRG has been the topic of a number of research analyst reports. Robert W. Baird upped their target price on Intuitive Surgical from $513.00 to $550.00 and gave the stock an "outperform" rating in a report on Wednesday, October 21st. Sanford C. Bernstein reissued an "outperform" rating on shares of Intuitive Surgical in a research report on Wednesday, August 12th. KeyCorp restated an "overweight" rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a research report on Wednesday, October 21st. Finally, BMO Capital Markets restated an "outperform" rating on shares of Intuitive Surgical in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating, five have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $493.54.
Get Our Latest Stock Report on ISRG
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company's primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.
The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
